Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 75.28 M78.11 M78.07 M81.72 M 313.18 M Research & development ———— — Operating income 25.9 M17.87 M23.12 M31.74 M 98.63 M Non-Operating Income, Total -521 K-522 K-615 K-497 K -2.15 M Interest expense, net of interest capitalized 1.91 M1.95 M1.3 M1.43 M 6.59 M Non-Operating Income, excl. Interest Expenses -2.26 M-2.6 M-1.7 M-1.63 M -8.19 M Unusual income/expense -173 K136 K-216 K-302 K -555 K Pretax income 27 M19.42 M24.05 M33.27 M 103.74 M Equity in earnings ———— — Taxes 7.12 M2.93 M7.17 M7.66 M 24.87 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 19.88 M16.49 M16.89 M25.62 M 78.87 M Discontinued operations ———— — Net income 19.88 M16.49 M16.89 M25.62 M 78.87 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 19.88 M16.49 M16.89 M68.47 M 121.73 M Basic earnings per share (Basic EPS) 0.90.750.791.25 3.69 Diluted earnings per share (Diluted EPS) 0.890.750.783.16 3.64 Average basic shares outstanding 22.02 M21.86 M21.3 M21.38 M — Diluted shares outstanding 22.41 M22.11 M21.58 M21.69 M — EBITDA -51.3 M-63.9 M-54.74 M— — EBIT -57.5 M-69.84 M-60.45 M— — Cost of revenue 632.18 M663.6 M659.67 M833.26 M 2.79 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 6.2 M5.94 M5.71 M5.78 M 23.63 M